Some fascinating statistics about LCTC:
At Lifeloc's current price the entire stock float can be locked up for a mere $1.6 Million (Current float of 289,999 x Current price $5.50) There are not too many other stocks where the entire stock float can be bought for less than $2 Million.
Lifeloc's closest competitor in the marijuana breathalyzer sector would be Cannabix (BLOZF). Cannabix has a current market cap of $190 Million (91.31 Million shares outstanding x Current price of $2.10). Lifeloc has a market cap of of just $13.5 Million (2.45 Million shares outstanding x Current Price $5.50) . The market is valuing Cannabix at 14 times that of Lifeloc. Cannabix has never had a sale, revenue, or profit in its company's history. Lifeloc has been profitable with revenues over $6 million every year since it has been a public company.
Lifeloc has made a nice run in the January time frame 2 out of the last 3 years. We have to see if that trend will continue but the Marijuana/Cannabis space has been on a tear the last couple weeks and with Lifeloc trading near the $5 level, I have to think this is a good pick up here.
Lifeloc has total assets of $8.3 million and cash of $2.7 million.
We look to the future for some significant product launches. We expect to introduce a completely new breathalyzer with the features that customers have been seeking. Likewise, we expect to reintroduce the R.A.D.A.R. device with better communications and a more robust mechanical design, improving service life. Development work continues on the real time, quantitative analysis for a panel of drugs including THC utilizing the SpinDx™ technology licensed from Sandia Corporation and the closely related THC breathalyzer. This work has demonstrated the detection of very low quantities of THC, but more work is needed to reduce this to a practical device. The Lifeloc commitment to innovation remains as strong as ever.”
